Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGLS Regulus Therapeutics Inc

休市中 08-23 16:00:00 EDT

1.77

+0.15

+9.26%

盘后1.77

+0.000.00%

19:52 EDT

最高1.78	最低1.60	成交量42.36万
今开1.60	昨收1.62	日振幅11.11%
总市值1.16亿	流通市值7,501万	总股本6,547万
成交额73.69万	换手率1.00%	流通股本4,238万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGLS","market":"US","secType":"STK","nameCN":"Regulus Therapeutics Inc","latestPrice":1.77,"timestamp":1724443200000,"preClose":1.62,"halted":0,"volume":423614,"hourTrading":{"tag":"盘后","latestPrice":1.77,"preClose":1.77,"latestTime":"19:52 EDT","volume":12494,"amount":22114.2872,"timestamp":1724457145731},"delay":0,"floatShares":42378176,"shares":65465876,"eps":-1.05567,"marketStatus":"休市中","marketStatusCode":7,"change":0.15,"latestTime":"08-23 16:00:00 EDT","open":1.6,"high":1.78,"low":1.6,"amount":736898.2420368,"amplitude":0.111111,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.05567,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1349323200000,"adjPreClose":1.62,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.605,"preClose":1.62,"latestTime":"09:27 EDT","volume":33,"amount":53.0866017,"timestamp":1724419634389},"postHourTrading":{"tag":"盘后","latestPrice":1.77,"preClose":1.77,"latestTime":"19:52 EDT","volume":12494,"amount":22114.2872,"timestamp":1724457145731},"volumeRatio":1.3398637405286113,"impliedVol":1.6485,"impliedVolPercentile":0.1786},"requestUrl":"/m/hq/s/RGLS","defaultTab":"news","newsList":[{"id":"2461874921","title":"Regulus Therapeutics Inc.盘中异动 急速拉升5.03%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461874921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461874921?lang=zh_cn&edition=full","pubTime":"2024-08-22 02:02","pubTimestamp":1724263326,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日02时02分，Regulus Therapeutics Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报1.67美元/股，成交量21.7861万股，换手率0.33%，振幅6.92%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822020207a1d57a2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822020207a1d57a2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2460004440","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨6.33%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004440","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004440?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:31","pubTimestamp":1724160701,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时31分，Regulus Therapeutics Inc.股票出现异动，股价快速拉升6.33%。截至发稿，该股报1.68美元/股，成交量1756股，换手率0.00%，振幅1.58%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021314298e35833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021314298e35833&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2460241025","title":"Regulus Therapeutics Inc.2024财年第二财季实现净利润-11.04百万美元，同比减少57.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460241025","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460241025?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824037,"startTime":"0","endTime":"0","summary":"8月17日，Regulus Therapeutics Inc.公布财报，公告显示公司2024财年第二财季净利润为-11.04百万美元，同比减少57.49%；其中营业收入为0.00美元，每股基本收益为-0.17美元。从资产负债表来看，Regulus Therapeutics Inc.总负债5.94百万美元，其中短期债务747000.00美元，资产负债比为0.18，流动比率为18.48。机构评级：截至2024年8月17日，当前有6家机构对Regulus Therapeutics Inc.目标价做出预测，其中目标均价为10.33美元，其中最低目标价为3.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000558959f2d1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240817000558959f2d1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS"],"gpt_icon":0},{"id":"2459378420","title":"Regulus Therapeutics Inc.盘中异动 早盘股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459378420","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459378420?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:34","pubTimestamp":1723728843,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时34分，Regulus Therapeutics Inc.股票出现异动，股价急速上涨5.19%。截至发稿，该股报1.62美元/股，成交量1.2679万股，换手率0.02%，振幅1.95%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Cingulate Inc.、Nutriband Inc C/Wts 、Scisparc Ltd.涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2692.52%、1521.47%、342.45%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Cingulate Inc C/Wts 10/12/2026 、Cingulate Inc.，振幅分别为52.18%、32.31%、30.35%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213404a1d4709d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213404a1d4709d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2459110434","title":"Regulus Therapeutics Inc.盘中异动 急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459110434","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459110434?lang=zh_cn&edition=full","pubTime":"2024-08-15 00:03","pubTimestamp":1723651415,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日00时03分，Regulus Therapeutics Inc.股票出现波动，股价大幅下跌5.03%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Newamsterdam Pharma Co Nv C/Wts 、Zura Bio Limited C/Wts 、Unicycive Therapeutics, Inc.涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为90.09%、77.63%、67.84%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815000335968263c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815000335968263c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2458984338","title":"Regulus Therapeutics Inc.盘中异动 急速拉升5.07%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458984338","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458984338?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:27","pubTimestamp":1723472835,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时27分，Regulus Therapeutics Inc.股票出现波动，股价大幅拉升5.07%。截至发稿，该股报1.56美元/股，成交量7.4128万股，换手率0.11%，振幅4.73%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812222716aefe6cff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812222716aefe6cff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2457021218","title":"Regulus Therapeutics Inc.盘中异动 快速拉升5.30%报1.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457021218","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457021218?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:54","pubTimestamp":1722956097,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时54分，Regulus Therapeutics Inc.股票出现异动，股价快速拉升5.30%。截至发稿，该股报1.59美元/股，成交量9.237万股，换手率0.14%，振幅7.28%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为2.19%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806225458941fea80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806225458941fea80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2457751797","title":"Regulus Therapeutics Inc.盘中异动 股价大跌7.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457751797","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457751797?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:40","pubTimestamp":1722865255,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时40分，Regulus Therapeutics Inc.股票出现异动，股价急速下跌7.01%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为2.18%。其相关个股中，Zevra Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Cervomed Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1092.89%、54.23%、14.18%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Alterity Therapeutics Limited、60 Degrees Pharmaceuticals, Inc.，振幅分别为21.59%、20.00%、17.81%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521405596823f50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080521405596823f50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2456257959","title":"Regulus Therapeutics Inc.盘中异动 临近收盘股价大跌5.00%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456257959","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456257959?lang=zh_cn&edition=full","pubTime":"2024-08-03 03:44","pubTimestamp":1722627865,"startTime":"0","endTime":"0","summary":"北京时间2024年08月03日03时44分，Regulus Therapeutics Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报1.62美元/股，成交量29.964万股，换手率0.46%，振幅5.29%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为1.72%。其相关个股中，Os Therapies Incorporated、Exicure, Inc.、Dermata Therapeutics, Inc.涨幅较大，Dermata Therapeutics, Inc.、Exicure, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为5431.87%、754.73%、179.35%，振幅较大的相关个股有Os Therapies Incorporated、Exicure, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为79.69%、64.24%、60.61%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080303442596823580&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080303442596823580&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2456285339","title":"Regulus Therapeutics Inc    预计每股亏损 12 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456285339","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456285339?lang=zh_cn&edition=full","pubTime":"2024-08-02 20:59","pubTimestamp":1722603566,"startTime":"0","endTime":"0","summary":"   * Regulus Therapeutics Inc    将于8月6日公布截至2024年6月30日的财报() 预计季度营收将保持不变。*    * LSEG分析师对Regulus Therapeutics Inc的平均预期为每股亏损12美分。* 目前，分析师对该公司股票的平均评级为 \"买入\"，推荐值细分为 5 个 \"强烈买入 \"或 \"买入\"，1 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Regulus Therapeutics Inc 的 12 个月目标价中位数为 7.50 美元，高于其上一次收盘价 1.70 美元。8月2日 - 以往季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGLS","LENZ"],"gpt_icon":0},{"id":"2456451553","title":"Regulus Therapeutics Inc.盘中异动 急速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456451553","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456451553?lang=zh_cn&edition=full","pubTime":"2024-08-02 01:15","pubTimestamp":1722532523,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日01时15分，Regulus Therapeutics Inc.股票出现波动，股价大幅跳水5.00%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Dermata Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Dermata Therapeutics, Inc.、Windtree Therapeutics, Inc.、Immuneering Corporation较为活跃，换手率分别为2264.06%、350.79%、212.55%，振幅较大的相关个股有Dermata Therapeutics, Inc.、Virax Biolabs Group Limited、Biomea Fusion, Inc.，振幅分别为57.55%、43.37%、43.27%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080201152396822c44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080201152396822c44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2455329953","title":"Regulus Therapeutics Inc.盘中异动 快速上涨6.01%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455329953","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455329953?lang=zh_cn&edition=full","pubTime":"2024-07-30 22:00","pubTimestamp":1722348028,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日22时00分，Regulus Therapeutics Inc.股票出现波动，股价大幅拉升6.01%。截至发稿，该股报1.94美元/股，成交量5.5754万股，换手率0.09%，振幅4.92%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730220029968219e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730220029968219e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2454011038","title":"Regulus Therapeutics Inc.盘中异动 股价大涨5.71%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454011038","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454011038?lang=zh_cn&edition=full","pubTime":"2024-07-26 00:12","pubTimestamp":1721923940,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日00时12分，Regulus Therapeutics Inc.股票出现异动，股价大幅上涨5.71%。截至发稿，该股报1.85美元/股，成交量58.7694万股，换手率0.90%，振幅6.81%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Viking Therapeutics, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Psyence Biomedical Ltd.、Exicure, Inc.较为活跃，换手率分别为3932.10%、539.16%、276.43%，振幅较大的相关个股有Psyence Biomedical Ltd.、Exicure, Inc.、Salarius Pharmaceuticals, Inc.，振幅分别为151.18%、132.26%、98.60%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726001221941faab9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726001221941faab9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RGLS","BK4139"],"gpt_icon":0},{"id":"2451996727","title":"HC Wainwright &amp; Co.：重申Regulus Therapeutics(RGLS.US)评级，由买入调整至买入评级, 目标价由10.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451996727","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451996727?lang=zh_cn&edition=full","pubTime":"2024-07-16 20:10","pubTimestamp":1721131857,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2451623803","title":"Regulus Therapeutics Inc.盘中异动 早盘急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451623803","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451623803?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:35","pubTimestamp":1721050556,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时35分，Regulus Therapeutics Inc.股票出现波动，股价大幅拉升5.26%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Aeon Biopharma, Inc.、Enveric Biosciences, Inc.涨幅较大，Artelo Biosciences, Inc.、Qualigen Therapeutics, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为93.77%、50.63%、22.62%，振幅较大的相关个股有Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为18.40%、17.50%、11.17%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152135569681ccf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152135569681ccf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2450811816","title":"Regulus Therapeutics Inc.盘中异动 急速上涨5.36%报1.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450811816","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450811816?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:09","pubTimestamp":1720620592,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时09分，Regulus Therapeutics Inc.股票出现异动，股价急速拉升5.36%。截至发稿，该股报1.77美元/股，成交量11.0552万股，换手率0.17%，振幅5.95%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Virpax Pharmaceuticals, Inc.、Longeveron Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Longeveron Inc.较为活跃，换手率分别为2372.84%、1035.25%、652.71%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Kazia Therapeutics Limited、Longeveron Inc.，振幅分别为119.83%、62.50%、59.23%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710220953941f5d7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710220953941f5d7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","BK4139","LENZ"],"gpt_icon":0},{"id":"2450214077","title":"Regulus Therapeutics Inc.盘中异动 临近收盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450214077","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450214077?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:57","pubTimestamp":1720555070,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时57分，Regulus Therapeutics Inc.股票出现异动，股价快速下挫5.11%。截至发稿，该股报1.67美元/股，成交量24.2592万股，换手率0.37%，振幅9.38%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710035750af9161b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710035750af9161b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0},{"id":"2449706803","title":"Regulus Therapeutics Inc.盘中异动 急速上涨6.02%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449706803","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449706803?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:41","pubTimestamp":1720446088,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日21时41分，Regulus Therapeutics Inc.股票出现异动，股价快速上涨6.02%。截至发稿，该股报1.76美元/股，成交量5766股，换手率0.01%，振幅4.22%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708214129941f4ed6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708214129941f4ed6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2448947543","title":"Regulus Therapeutics Inc.盘中异动 大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448947543","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448947543?lang=zh_cn&edition=full","pubTime":"2024-07-02 03:58","pubTimestamp":1719863881,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日03时58分，Regulus Therapeutics Inc.股票出现异动，股价快速拉升5.04%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Senti Biosciences, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为842.33%、211.30%、136.74%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Senti Biosciences, Inc.、Cingulate Inc.，振幅分别为168.39%、101.49%、82.81%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702035801968187d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702035801968187d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGLS","LENZ","BK4139"],"gpt_icon":0},{"id":"2446268368","title":"Regulus Therapeutics Inc.盘中异动 大幅下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446268368","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446268368?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581505,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时31分，Regulus Therapeutics Inc.股票出现波动，股价快速下跌5.19%。Regulus Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Regulus Therapeutics Inc.公司简介：Regulus Therapeutics Inc是一家专注于microRNA疗法开发的生物技术公司。消息层面，截至21时31分，《JonesTrading维持Regulus Therapeutics买入评级，维持目标价8美元》资讯为影响Regulus Therapeutics Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213145aef72885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628213145aef72885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RGLS","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.regulusrx.com","stockEarnings":[{"period":"1week","weight":0.0994},{"period":"1month","weight":0.0114},{"period":"3month","weight":-0.1238},{"period":"6month","weight":0.2123},{"period":"1year","weight":0.0057},{"period":"ytd","weight":0.3828}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Regulus Therapeutics Inc.成立于2007年9月6日。该公司是一家临床阶段的生物制药公司，致力于发现和开发针对microRNA的一流药物，以治疗具有重大医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.583333,"avgChangeRate":-0.016722},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.00374},{"month":3,"riseRate":0.5,"avgChangeRate":0.090028},{"month":4,"riseRate":0.25,"avgChangeRate":-0.057759},{"month":5,"riseRate":0.583333,"avgChangeRate":0.084394},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.119338},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.130856},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.038091},{"month":9,"riseRate":0.363636,"avgChangeRate":0.00074},{"month":10,"riseRate":0.181818,"avgChangeRate":0.034742},{"month":11,"riseRate":0.416667,"avgChangeRate":0.053637},{"month":12,"riseRate":0.416667,"avgChangeRate":0.0557}],"exchange":"NASDAQ","name":"Regulus Therapeutics Inc","nameEN":"Regulus Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Regulus Therapeutics Inc,RGLS,Regulus Therapeutics Inc股票,Regulus Therapeutics Inc股票老虎,Regulus Therapeutics Inc股票老虎国际,Regulus Therapeutics Inc行情,Regulus Therapeutics Inc股票行情,Regulus Therapeutics Inc股价,Regulus Therapeutics Inc股市,Regulus Therapeutics Inc股票价格,Regulus Therapeutics Inc股票交易,Regulus Therapeutics Inc股票购买,Regulus Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Regulus Therapeutics Inc(RGLS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Regulus Therapeutics Inc(RGLS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}